Home
Conditions
Stage III Renal Cell Cancer AJCC v8

Clinical trial condition

Stage III Renal Cell Cancer AJCC v8

Explore clinical trials studying Stage III Renal Cell Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

34 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Stage III Renal Cell Cancer AJCC v8 trial results

Recruiting

Imaging of Solid Tumors Using 18F-TRX

NCT06942104

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT05092373

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

NCT07128680

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +20 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Medical Center Irvine, California, United States

View Trial Details

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View all 13 locations

View Trial Details

Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

NCT05327686

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View all 328 locations

View Trial Details

Recruiting

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT05269381

Conditions: Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

NCT07405086

Conditions: Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +63 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

NCT07383441

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations: Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

Highlands Oncology Group - Rogers Rogers, Arkansas, United States

Highlands Oncology Group Springdale, Arkansas, United States

View all 41 locations

View Trial Details

Recruiting

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

NCT07226544

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

NCT06265285

Conditions: Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Stage III Renal Cell Cancer AJCC v8

Stage III Renal Cell Cancer AJCC v8 trial results

Related conditions